FTC to look into drugmakers

Korea’s antitrust regulator has embarked on looking into the intellectual property rights of the pharmaceutical industry following its longstanding investigation into the drug makers’ undue business practices such as rebate-offering.

The Fair Trade Commission (FTC) said on June 21 that the business regulator has decided to conduct its written investigation on problems from the intellectual p...